Born 1957. Chairman of the Board of Directors since 2020.
Independent in relation to the Company and its management but independent in relation to major shareholders..
Education and experience: M.Sc. Chemical Engineering, Chalmers University of Technology, Ph.D. Department of Pure and Applied Biochemistry, Lund Institute of Technology, University of Lund. Lars has 30 years’ experience from leading positions in life science companies. A large part of his career has involved research and development at for example AstraZeneca but Lars also has a vast experience in founding, running and developing companies in life science.
Current assignments: Chairman and co-founder of IAmPatient AB, Chairman of the board at Asgard Therapeutics AB, alternate board member of CanImGuide AB and Immodulate AB, board member of RhoVac AB (publ) and Cell Invent AB, and adjunct board member of Xintela AB.
Previous assignments (last five years): CEO of Idogen AB, Acting CEO of Pharmiva AB and Chairman of the Board of Directors of Lund Life Science Incubator.
Lars Hedbys holds 1,282 B-shares via company.